{"bill": {"#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n  ", "legis-num": {"#tail": "\n    ", "#text": "S. 2141"}, "official-title": {"#tail": "\n  ", "#text": "To amend the Federal Food, Drug, and Cosmetic Act to provide an alternative process for\n\t\t\t review of safety and effectiveness of nonprescription sunscreen active\n\t\t\t ingredients and for other purposes. "}, "session": {"#tail": "\n    ", "#text": "2d Session"}, "distribution-code": {"#tail": "\n    ", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n      ", "@date": "20140313", "#text": "March 13, 2014"}, "#tail": "\n    ", "action-desc": {"#tail": "\n    ", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor, and Pensions"}, "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Reed", "@name-id": "S259"}, "cosponsor": {"#tail": ") introduced the following bill; which was read twice and referred to the ", "#text": "Mr. Isakson", "@name-id": "S305"}}, "#text": "\n      "}, "legis-type": {"#tail": "\n    ", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Sunscreen Innovation\n\t\t\t Act", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as\n\t\t\t the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short\n\t\t\t title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Subchapter A of chapter V", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:A"}, {"#tail": ".)", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et\n\t\t\t seq", "@value": "usc/21/351/etseq"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Regulation of\n\t\t\t nonprescription sunscreen active ingredients"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n    ", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "524B."}, "header": {"#tail": "\n          ", "#text": "Procedures\n\t\t\t\tfor classifying sunscreen active ingredients"}, "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall review and determine whether nonprescription sunscreen\n\t\t\t conditions are\n\t\t\t\tgenerally recognized as safe and effective and shall ensure that\n\t\t\t any such\n\t\t\t conditions that\n\t\t\t\tare marketed in the United States are appropriately labeled.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "In general"}, "#text": "\n            ", "@id": "id32E4E2EFAED14A7AAC64B0F202539F26", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "term": {"#tail": " means any\n\t\t\t\tcomponent that is intended to furnish pharmacological activity or\n\t\t\t other direct\n\t\t\t\teffect in the diagnosis, cure, mitigation, treatment, or prevention\n\t\t\t of disease,\n\t\t\t\tor to affect the structure or function of the body of humans or\n\t\t\t animals.\n\t\t\t\tThe term includes components that may undergo chemical change in\n\t\t\t the\n\t\t\t\tmanufacture of a drug and may be present in a drug in a\n\t\t\t modified form\n\t\t\t\tintended to furnish the specified activity or effect.", "#text": "active ingredient"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Active\n\t\t\t\tingredient"}, "#text": "\n              ", "@id": "idbb0dd6f7fe0f4a6b87a99e3379f0c6fe"}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "term": {"#tail": " means an active ingredient that absorbs, reflects, or\n\t\t\t\tscatters radiation in the ultraviolet range at wavelengths from 290\n\t\t\t to 400\n\t\t\t\tnanometers.", "#text": "sunscreen active\n\t\t\t\tingredient"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Sunscreen\n\t\t\t\tactive ingredient"}, "#text": "\n              ", "@id": "id9629e772152d43fa9dc1276a8d726694"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "term": {"#tail": " means a sunscreen active ingredient (or a combination of sunscreen active ingredients), dosage\n\t\t\t form, dosage strength, or route of administration, marketed for a specific\n\t\t\t nonprescription use.", "#text": "sunscreen condition"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Sunscreen\n\t\t\t\tcondition"}, "#text": "\n              ", "@id": "id8561239ab2cb45fd834a2a95f51d75d6"}], "#text": "\n            ", "@id": "idA93947450E6F434F85AC2E1E23851A37"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "To be eligible for review under this section, a sunscreen condition shall\u2014"}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Criteria for\n\t\t\t\teligibility"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "not be included in the stayed sunscreen\n\t\t\t monograph; and"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "#text": "\n              ", "@id": "id288B75FD386948B3A45199BC461DF7A8", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n              ", "#text": "have been marketed as a  nonprescription sunscreen condition in the United States or at least 1\n\t\t\t other country, or marketed as a cosmetic or dietary supplement in 1 or\n\t\t\t more counties other than the United States\u2014"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "id8EBF62253C81420A94AE9663F843E36E", "@commented": "no", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "for a minimum of 5 continuous years; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "#text": "\n                ", "@id": "idD57880AC2D144B8BAC3BD30085F11D4D", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subparagraphs (D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:1/sp:D", "@proposed": "true"}, {"#tail": " and, if\n\t\t\t applicable, ", "@entity-type": "act", "#text": "(E) of subsection (d)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:1/sp:E", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (d)(2)(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "in sufficient quantity, as determined by the Secretary based upon the information submitted under\n\t\t\t "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "id475D4875468B4338920DFBFB07FD6EA0", "@commented": "no"}]}], "#text": "\n            ", "@id": "id008fa93ba90749c49b80c64ebbd3f0b1", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(d)"}, "header": {"#tail": "\n            ", "#text": "Application for eligibility"}, "paragraph": [{"#tail": "\n            ", "@id": "idE1C65F76DFF84F479BC736A8EC056FD3", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " desiring to market such condition in\n\t\t\t the United\n\t\t\t\tStates may submit an application to the ", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:c", "@proposed": "true"}, {"#tail": ", in such manner\n\t\t\t and\n\t\t\t\tcontaining such information as required by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", including\n\t\t\t the\n\t\t\t\tfollowing:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "A sponsor of a nonprescription sunscreen condition\n\t\t\t\tdescribed in "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "Basic information\n\t\t\t\tabout the sunscreen condition (including a description of each\n\t\t\t active\n\t\t\t\tingredient, pharmacologic class, intended nonprescription use,\n\t\t\t nonprescription\n\t\t\t\tstrength and dosage form, route of administration, and directions\n\t\t\t for\n\t\t\t\tuse)."}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "idc5a86345742f479ca86d3619d29d5883", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "A detailed chemical description of the sunscreen active ingredient that includes a full description\n\t\t\t of the drug substance, including its physical and chemical\n\t\t\t characteristics, the method of synthesis (or isolation) and purification\n\t\t\t of the drug substance, and any specifications and analytical methods\n\t\t\t necessary to ensure the identity, strength, quality, and purity of the\n\t\t\t drug substance, including reference to the current edition of the official\n\t\t\t National Formulary, the United States Pharmacopeia, or foreign\n\t\t\t compendiums, where applicable."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "idB3B88ED18E7E4087945530AF0E7FE45D", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "A list of each\n\t\t\t\tcountry in which the sunscreen condition has been marketed."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "idFDA28802F6CE48169B68729D97DE7788", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "The cumulative\n\t\t\t\ttotal number of dosage units sold for each dosage form of the\n\t\t\t sunscreen\n\t\t\t\tcondition, including total weight of the active ingredient, package\n\t\t\t size for\n\t\t\t\teach dosage form in which the condition is marketed as\n\t\t\t nonprescription, and an\n\t\t\t\testimate of the minimum number of potential consumer exposures to\n\t\t\t the\n\t\t\t\tcondition."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "idE04D9F0B12114819949DE356BD1098CB", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "The use pattern\n\t\t\t\t(according to the label) for each country in which the sunscreen\n\t\t\t condition is\n\t\t\t\tmarketed and any changes in use pattern that have occurred over\n\t\t\t time."}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "idE6804C8AF2D844EBA4D2BBFED21EC261", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "A list of all\n\t\t\t\tcountries in which the sunscreen condition has been withdrawn from\n\t\t\t marketing or\n\t\t\t\tin which an application for nonprescription marketing approval has\n\t\t\t been denied\n\t\t\t\tand an explanation for such withdrawal or application denial."}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "id8c39d2b897f8434682f6790f81c21685", "#text": "\n                "}]}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may require supplemental information.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The manner in\n\t\t\t\twhich the sunscreen condition has been marketed to consumers. If\n\t\t\t the sunscreen\n\t\t\t\tcondition is marketed to consumers as a nonprescription pharmacy\n\t\t\t only\n\t\t\t\tcondition, the "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id7153F824D631477A91F95602857D8354", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "A description of the population demographics and the source from which this information has been\n\t\t\t compiled, to ensure that the sunscreen condition's use can be reasonably\n\t\t\t extrapolated to the population of the United States."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "#text": "\n                  ", "@id": "id199F176CAB4F4E0083A97C5465E7B271", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "A description of\n\t\t\t\tthe country\u2019s system for identifying adverse drug experiences,\n\t\t\t especially those\n\t\t\t\tfound in nonprescription marketing experience, including method of\n\t\t\t collection\n\t\t\t\tif applicable."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "id924AD15457324C939B9524673D958FB8", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "A statement of how long the sunscreen condition has been marketed in each country and how long the\n\t\t\t current product labeling has been in use, accompanied by a copy of the\n\t\t\t current product labeling, including a translation into English of any\n\t\t\t labeling that is not in English, and a statement of whether the current\n\t\t\t product labeling has been authorized, accepted, or approved by a\n\t\t\t regulatory body in\n\t\t\t each country where the condition is marketed."}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "id7926B88CB2FF4722804A49861A3E1398", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "A list of all\n\t\t\t\tcountries where the sunscreen condition is marketed as a\n\t\t\t prescription drug only\n\t\t\t\tand an explanation for such restriction."}, "enum": {"#tail": "\n                  ", "#text": "(v)"}, "@id": "idDD9CBBFA1BBF4EC9B20D46671242E4B8", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In general"}, "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the sponsor shall submit the following information for each\n\t\t\t\tcountry in which the sunscreen condition has been marketed:", "@entity-type": "act", "#text": "paragraph\n\t\t\t (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:1", "@proposed": "true"}, "#text": "In the case of an application with respect to a nonprescription sunscreen condition that has not\n\t\t\t been marketed in the United States for 5 continuous years, in addition to\n\t\t\t the information required under "}, "#text": "\n                ", "@id": "id7E9940EF6C484F1BB4D4A1686F6D521D", "@commented": "no"}, {"#tail": "\n            ", "clause": [{"#tail": "\n                ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n                    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to only 5 such countries, including\u2014", "@entity-type": "act", "#text": "clauses (i) through (iv) of\n\t\t\t subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:2/sp:A/cl:i..iv", "@proposed": "true"}, "#text": "may submit information in accordance with "}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "item": [{"#tail": "\n                    ", "text": {"#tail": "\n                    ", "#text": "the country with a\n\t\t\t minimum\n\t\t\t of 5 continuous years of nonprescription marketing;"}, "enum": {"#tail": "\n                      ", "#text": "(aa)"}, "@id": "id882E69A83AB74FC99657581E1C87A390", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n                    ", "#text": "the country with \n\t\t\t the longest duration of marketing; and"}, "enum": {"#tail": "\n                      ", "#text": "(bb)"}, "@id": "id0464FAD816BC4E23BE7CB1157BB2BE1F", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n                    ", "#text": "the country with the most support\n\t\t\t for marketing, such as a large volume of sales with cultural\n\t\t\t diversity among users of the product; and"}, "enum": {"#tail": "\n                      ", "#text": "(cc)"}, "@id": "id86F9A2F2BD05409F875AE30106BB0686", "#text": "\n                      "}], "#text": "\n                    ", "@id": "id25DF5101CF2F461A9D0B82EB70CFB34B"}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "subclause (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:2/sp:B/cl:i/scl:I", "@proposed": "true"}, "#text": "shall explain the basis for the countries selected under "}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "id7E07931F6C504836B20908F657B3CAFB", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n                  ", "#text": "shall provide information from more than 5\n\t\t\t countries if such information is needed to support the application."}, "enum": {"#tail": "\n                    ", "#text": "(III)"}, "@id": "id1D20F7645EFC4EBCAA80AF0DD1A57F0B", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(i)"}, "header": {"#tail": "\n                  ", "#text": "In general"}, "text": {"#tail": "\n                  ", "#text": "In the case of a sunscreen condition that has been marketed as a nonprescription sunscreen in more\n\t\t\t than 5 countries, with a\n\t\t\t minimum of 5 continuous years of marketing in at least one such country,\n\t\t\t the\n\t\t\t sponsor\u2014"}, "#text": "\n                  ", "@id": "id2BD00871B62245DBA950594D3343E3D7"}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " in 1 or\n\t\t\t more countries listed in ", "@entity-type": "act", "#text": "items (aa) through (cc) of clause (i)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:2/sp:B/cl:i/scl:I/i:aa..cc", "@proposed": "true"}, {"#tail": ", at least 1 such country\n\t\t\t shall be included among the 5 countries selected under such ", "@entity-type": "act", "#text": "section 802(b)(1)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:802/ss:b/p:1/sp:A"}, {"#tail": ".", "@entity-type": "act", "#text": "clause (i)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:2/sp:B/cl:i/scl:I", "@proposed": "true"}], "#text": "If the sunscreen condition\n\t\t\t meets the criteria under "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "header": {"#tail": "\n                  ", "#text": "Requirement"}, "#text": "\n                  ", "@id": "idC3054B5C4A4744479F81962DA37A0DC5"}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Sunscreen conditions that have been marketed in more than 5 countries"}, "#text": "\n                ", "@id": "id1E7DBBAF279D443BA83EFA5BB855722A"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Sunscreen conditions that have not been marketed in the United States for 5 continuous years"}, "#text": "\n              ", "@id": "iddbf8aaf6a9554fd7a4ff98ee7e7445bf", "@commented": "no"}, {"#tail": "\n          ", "text": {"short-title": {"#tail": ". Applications for such sunscreen conditions shall be\n\t\t\t\tconsidered in accordance with ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "Sunscreen Innovation\n\t\t\t\tAct", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                  "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:g", "@proposed": "true"}, "#tail": "\n            ", "#text": "The requirements of this subsection shall not apply\n\t\t\t\tto a sunscreen condition deemed eligible for review of safety and\n\t\t\t effectiveness\n\t\t\t\tby publication of a notice of eligibility in the Federal Register\n\t\t\t prior to the\n\t\t\t\tdate of enactment of the "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Pending\n\t\t\t\tapplications"}, "#text": "\n              ", "@id": "id835519D888CC4BD3868F1B5041AE175B", "@commented": "no"}], "#text": "\n            ", "@id": "id18e25fa5485441e5be10d04e180d4865"}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d", "@proposed": "true"}, {"#tail": " shall make the application publicly available,\n\t\t\t with\n\t\t\t\tredactions for confidential commercial information or trade secret\n\t\t\t information,\n\t\t\t\tand any other information exempt from disclosure pursuant to\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", ", "@entity-type": "uscode", "#text": "section 1905 of\n\t\t\t\ttitle 18, United States Code", "@value": "usc/18/1905"}, {"#tail": ", or\n\t\t\t\t", "@entity-type": "uscode", "#text": "\n                ", "external-xref": {"#tail": " of title 5, United\n\t\t\t States Code", "@parsable-cite": "usc/5/552", "#text": "section 552(b)", "@legal-doc": "usc"}, "@value": "usc/5/552/b"}, {"#tail": " of this Act. Applications shall remain confidential\n\t\t\t during the\n\t\t\t\t", "@entity-type": "act", "#text": "section 301(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:j"}, {"#tail": " consideration of eligibility.", "@entity-type": "federal-body", "#text": "Secretary's", "@entity-id": "7500"}], "#text": "If a condition is found eligible under "}, "enum": {"#tail": "\n            ", "#text": "(e)"}, "header": {"#tail": "\n            ", "#text": "Public\n\t\t\t\tavailability"}, "#text": "\n            ", "@id": "id8c792c63bc7d44a6ac81335da7d53470", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(f)"}, "header": {"#tail": "\n            ", "#text": "New sunscreen\n\t\t\t\tcondition application"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d", "@proposed": "true"}, {"#tail": " shall determine if\n\t\t\t the sunscreen\n\t\t\t\tcondition is eligible for further review for safety and\n\t\t\t effectiveness. In the\n\t\t\t\tcase of a sunscreen condition determined to be eligible, the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall\n\t\t\t\tpublish a notice of eligibility in the Federal Register, and\n\t\t\t provide interested persons an opportunity to submit published and\n\t\t\t unpublished data related to the safety and effectiveness of the sunscreen\n\t\t\t condition for its intended nonprescription uses, in accordance with\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". In the\n\t\t\t\tcase of a sunscreen condition determined not eligible, the\n\t\t\t ", "@entity-type": "act", "#text": "paragraph\n\t\t\t (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2", "@proposed": "true"}, {"#tail": " shall\n\t\t\t\tissue a letter to the sponsor, which shall be made publicly\n\t\t\t available.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Not later than 60 days after the submission of an eligibility\n\t\t\t\tapplication under "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Eligibility\n\t\t\t\tdetermination"}, "#text": "\n              ", "@id": "id8623E80F7C2D4B6385D455FEAFD1C27A"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t the sponsor\n\t\t\t\tand other interested parties shall submit safety and effectiveness\n\t\t\t data to the\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:1", "@proposed": "true"}, {"#tail": " for further review, as described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2/sp:B", "@proposed": "true"}], "#text": "Within 60 days of the publication in the Federal Register\n\t\t\t\tof an application deemed eligible, as described in "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "id659349BE0F424806AD3D5D318DAD76A3"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "With respect to individual active components, controlled studies, partially controlled or\n\t\t\t uncontrolled studies,\n\t\t\t documented case reports, pertinent marketing experiences that may\n\t\t\t influence a determination as to the safety of each individual active\n\t\t\t component, and pertinent medical and scientific literature."}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "header": {"#tail": "\n                    ", "#text": "Individual active components"}, "#text": "\n                    ", "@id": "id2115070B46594576B5CC4F027D5B969A"}, {"#tail": "\n                ", "text": {"#tail": "\n                  ", "#text": "With respect to combinations of the individual active components, controlled studies,\n\t\t\t partially controlled or\n\t\t\t uncontrolled studies, documented case reports, pertinent marketing\n\t\t\t experiences that may influence a determination as to the safety of\n\t\t\t combinations of the individual active component, and pertinent medical and\n\t\t\t scientific literature."}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "header": {"#tail": "\n                    ", "#text": "Combinations of individual active components"}, "#text": "\n                    ", "@id": "id15C06EBF47FB4D018BF0A6AF12F66642"}], "enum": {"#tail": "\n                  ", "#text": "(i)"}, "header": {"#tail": "\n                  ", "#text": "Human safety data"}, "#text": "\n                  ", "@id": "idF98A4640F19A47699CF6F15B71785E9E"}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "With respect to individual active components, controlled studies, partially controlled or\n\t\t\t uncontrolled\n\t\t\t studies, documented case reports, pertinent marketing experiences that may\n\t\t\t influence a determination on the efficacy of each individual active\n\t\t\t component, pertinent medical and scientific literature."}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "header": {"#tail": "\n                    ", "#text": "Individual active components"}, "#text": "\n                    ", "@id": "idF6A6E648531D45F3ABFE3C6D47ABEBE4"}, {"#tail": "\n                ", "text": {"#tail": "\n                  ", "#text": "With respect to combinations of the individual active components, controlled studies,\n\t\t\t partially controlled or\n\t\t\t uncontrolled studies, documented case reports, pertinent marketing\n\t\t\t experiences that may influence a determination on the efficacy of\n\t\t\t combinations of the individual active components, and pertinent medical\n\t\t\t and scientific literature."}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "header": {"#tail": "\n                    ", "#text": "Combinations of individual active components"}, "#text": "\n                    ", "@id": "id9FB4AE5DDA3543E6AE5D73B220824838"}], "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "header": {"#tail": "\n                  ", "#text": "Efficacy data"}, "#text": "\n                  ", "@id": "idF1EDE7393E72430BB5E0FA5EFA78D245"}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "A summary of the data and views setting forth the medical rationale and purpose (or lack thereof)\n\t\t\t for the sunscreen condition and the scientific basis (or lack thereof) for\n\t\t\t the conclusion that the condition has been proven safe and effective for\n\t\t\t the intended use. If there is an absence of controlled studies in the\n\t\t\t material submitted, an explanation as to why such studies are not\n\t\t\t considered necessary must be included."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "header": {"#tail": "\n                  ", "#text": "Data setting forth medical rationale and purpose"}, "#text": "\n                  ", "@id": "idCB855D0C079241D89F236C1861C37B86"}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "An applicable United States Pharmacopoeia or National Formulary for the\n\t\t\t sunscreen active ingredient or a proposed standard for inclusion in an\n\t\t\t article to be recognized in an official drug monograph for the\n\t\t\t active ingredient, including information showing that the official or\n\t\t\t proposed compendial monograph for the active ingredient is consistent with\n\t\t\t the active ingredient used in the studies establishing safety and\n\t\t\t effectiveness and with the active ingredient marketed in the\n\t\t\t nonprescription product to a material extent and for a material time.\n\t\t\t If differences exist between the official or proposed compendial\n\t\t\t monograph for the active ingredient and the active ingredient that is the\n\t\t\t subject of the application, sponsor shall explain such differences."}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "header": {"#tail": "\n                  ", "#text": "Official drug monograph"}, "#text": "\n                  ", "@id": "id5698C72B269C4B028749E826EC33D0A7"}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", from each country\n\t\t\t where the\n\t\t\t condition has been or is currently marketed as a prescription drug or as a\n\t\t\t nonprescription drug or product.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "A list of all serious adverse drug experiences, as defined by the "}, "enum": {"#tail": "\n                  ", "#text": "(v)"}, "header": {"#tail": "\n                  ", "#text": "Adverse drug experiences"}, "#text": "\n                  ", "@id": "idBF48A72D26B8448A9D650A19F7F97A95"}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Required submissions regarding data"}, "text": {"#tail": "\n                ", "#text": "Submissions under this\n\t\t\t paragraph shall\n\t\t\t\tinclude the following:"}, "#text": "\n                ", "@id": "id7d5879909ed041cca05fc1653d5aa964"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",  the sponsor may submit information\n\t\t\t with respect to animal safety data, including controlled\n\t\t\t studies and partially controlled or uncontrolled\n\t\t\t studies, in the case of an application for individual active components,\n\t\t\t and controlled\n\t\t\t studies and partially controlled\n\t\t\t or uncontrolled studies in the case of an application for combinations of\n\t\t\t individual active components.", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2/sp:B", "@proposed": "true"}, "#text": "In addition to the information required under "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Optional animal safety data"}, "#text": "\n                ", "@id": "id8FC6E1BCF91A4C709A92BBED9A21BC42"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make data and information\n\t\t\t\tsubmitted by the sponsor, or pursuant to a notice requesting safety\n\t\t\t and\n\t\t\t\teffectiveness data published in the Federal Register, publicly\n\t\t\t available, with\n\t\t\t\tredactions for confidential commercial information or trade secret\n\t\t\t information,\n\t\t\t\tand any other information exempt from disclosure pursuant to\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", ", "@entity-type": "uscode", "#text": "section 1905 of\n\t\t\t\ttitle 18, United States Code", "@value": "usc/18/1905"}, {"#tail": ", or\n\t\t\t\t", "@entity-type": "uscode", "#text": "\n                    ", "external-xref": {"#tail": " of title 5, United\n\t\t\t States Code", "@parsable-cite": "usc/5/552", "#text": "section 552(b)", "@legal-doc": "usc"}, "@value": "usc/5/552/b"}, {"#tail": " of this Act.", "@entity-type": "act", "#text": "section 301(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:j"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "header": {"#tail": "\n                ", "#text": "Confidentiality\n\t\t\t\tof submissions"}, "#text": "\n                ", "@id": "id996d652280954e01ab7879f683fdc713", "@commented": "no"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Safety and\n\t\t\t\teffectiveness data submissions"}, "#text": "\n              ", "@id": "id69cdb37a1d0c4ea3ac8da22da3cd441a"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2", "@proposed": "true"}, {"#tail": " shall submit the application and the\n\t\t\t safety and\n\t\t\t\teffectiveness data submitted under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " to the\n\t\t\t Nonprescription Drugs\n\t\t\t\tAdvisory Committee (referred to in this section as the ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2", "@proposed": "true"}], "#text": "Not\n\t\t\t\tlater than 30 days after the end of the public comment period\n\t\t\t described in\n\t\t\t\t", "quote": {"#tail": ") for review.", "#text": "advisory\n\t\t\t\tcommittee"}}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "New sunscreen\n\t\t\t\tcondition application submission to the advisory committee"}, "#text": "\n              ", "@id": "idd2ac2ac6232a4248a1728e624d45e4be"}], "#text": "\n            ", "@id": "id4b2216a501564acca58dd5ca05ec1699"}, {"#tail": "\n          ", "text": {"short-title": [{"#tail": ", the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "act", "#text": "Sunscreen Innovation\n\t\t\t\tAct", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                "}, {"#tail": ", to be\n\t\t\t\teligible for review of safety and effectiveness and for which the\n\t\t\t information\n\t\t\t\trequired under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "act", "#text": "Sunscreen Innovation Act", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                "}], "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall submit to the advisory committee all safety and effectiveness data submitted\n\t\t\t with respect to each\n\t\t\t\tapplication for review of sunscreen conditions that the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t had\n\t\t\t\tdetermined, prior to the date of enactment of the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " has been submitted to the\n\t\t\t ", "@entity-type": "act", "#text": "subsection (f)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2", "@proposed": "true"}, {"#tail": " prior to\n\t\t\t\tsuch date of enactment.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#tail": "\n          ", "#text": "Not later than 30 days after the\n\t\t\t\tdate of enactment of the "}, "enum": {"#tail": "\n            ", "#text": "(g)"}, "header": {"#tail": "\n            ", "#text": "Pending\n\t\t\t\tsunscreen condition applications"}, "#text": "\n            ", "@id": "id196a47accc41461e9c07ae9cb2c876fe"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(h)"}, "header": {"#tail": "\n            ", "#text": "Review and\n\t\t\t\trecommendation for nonprescription sunscreen condition"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall require the advisory committee to\n\t\t\t\tevaluate the safety and effectiveness data submitted in accordance\n\t\t\t with\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " or ", "@entity-type": "act", "#text": "subsection (f)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:g", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n              ", "@id": "idB732E3D9AF8E448F8D3CC56EE5388CED"}, {"#tail": "\n            ", "@id": "id5B017840DE014C61B820B3DB25A3337A", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Standards"}, "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the\n\t\t\t\tadvisory committee shall use the regulations in effect at the time\n\t\t\t of the\n\t\t\t\tapplication, including regulations with respect to\u2014", "@entity-type": "act", "#text": "paragraph\n\t\t\t (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:1", "@proposed": "true"}, "#text": "In\n\t\t\t\tevaluating a nonprescription sunscreen condition under "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "the safety of the\n\t\t\t\tnonprescription sunscreen condition;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "idF8DCEA34B759446EBD914CC6F34EC708", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "the effectiveness\n\t\t\t\tof the nonprescription sunscreen condition;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "idF812C4339BE54A6297286BA928F8A1F0", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "the\n\t\t\t\tbenefit-to-risk ratio of the nonprescription sunscreen condition;\n\t\t\t and"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "idA60006EEA1AB4818B5037652848165B1", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "the labeling of\n\t\t\t\tthe nonprescription sunscreen condition."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "id8D3CB731E25846BDAEFC4122B9A5521E", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "The advisory committee\n\t\t\t\tshall have the authority to communicate with the sponsor and other\n\t\t\t individuals who submit data during the\n\t\t\t advisory\n\t\t\t\tcommittee's review, including requesting clarification or\n\t\t\t additional\n\t\t\t\tinformation."}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Communications\n\t\t\t\tbetween advisory committee and other individuals who submit data"}, "#text": "\n              ", "@id": "idBBE44FC14BB1427A993EC669DD640F0A"}, {"#tail": "\n          ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The sunscreen\n\t\t\t\tcondition is generally recognized as safe and effective (including\n\t\t\t any or all\n\t\t\t\tindications), including nonprescription sunscreen conditions for\n\t\t\t which a new\n\t\t\t\tdrug application has been approved by the "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "idb7a18bcbf7874495bf31066414a75240", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "Insufficient\n\t\t\t\tinformation has been provided to support a\n\t\t\t recommendation that\n\t\t\t\tthe sunscreen condition is generally recognized as safe and\n\t\t\t effective\n\t\t\t\t(including any or all indications)."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "id7f22e8b5e10244f7b8b66392cf74afa3", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t505(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, "#text": "The sunscreen\n\t\t\t\tcondition is not generally recognized as safe and effective to be\n\t\t\t marketed or sold, unless an\n\t\t\t\tapplication with respect to such condition is approved under\n\t\t\t "}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "idad086b07ae32464d9d453a5fd52ed841", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subsection (f)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:3", "@proposed": "true"}, {"#tail": ",\n\t\t\t\tthe advisory committee shall make one of the following\n\t\t\t recommendations to the\n\t\t\t\t", "@entity-type": "act", "#text": "(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:g", "@proposed": "true"}, {"#tail": ":", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For each such submission under "}, "#text": "\n                ", "@id": "idF05AAC231780454F88429340C188D6E4"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " not later\n\t\t\t\tthan 180 days after the advisory committee receives the application\n\t\t\t and data\n\t\t\t\tsubmitted under ", "@entity-type": "act", "#text": "subparagraph\n\t\t\t (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4/sp:A", "@proposed": "true"}, {"#tail": " or ", "@entity-type": "act", "#text": "subsection (f)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:3", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:g", "@proposed": "true"}], "#text": "The\n\t\t\t\tadvisory committee shall make a recommendation under "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Timing"}, "#text": "\n                ", "@id": "id8a1c3b1b6ac04c5cb1c50701b20c7efa", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the\n\t\t\t\tadvisory committee shall make such recommendation not later than\n\t\t\t 180 days after\n\t\t\t\tthe date on which such additional information is submitted.", "@entity-type": "act", "#text": "subparagraph\n\t\t\t (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4/sp:A/cl:ii", "@proposed": "true"}, "#text": "If the advisory committee recommends that insufficient\n\t\t\t\tinformation has been provided, in accordance with "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Resubmission of\n\t\t\t\tdata"}, "#text": "\n                ", "@id": "id3f9c00e70c6d40d58460ffedc1b1b510", "@commented": "no"}], "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Recommendations"}, "#text": "\n              ", "@id": "id56E48445242D4AF7A28F54DF4BBBC12A"}], "#text": "\n            ", "@id": "id113CBC59342646BC8B0BC3D20EA8968E"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(i)"}, "header": {"#tail": "\n            ", "#text": "Determination\n\t\t\t\tby the Center for Drug Evaluation and Research"}, "paragraph": [{"#tail": "\n            ", "@id": "id9691662fef1a478b8791cceb94bda2b6", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall respond\n\t\t\t\tto the recommendations of the advisory committee under ", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}, {"#tail": " as\n\t\t\t\tfollows:", "@entity-type": "act", "#text": "subsection\n\t\t\t (h)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4", "@proposed": "true"}], "#text": "The "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", not later than 45 days after the advisory\n\t\t\t committee issues\n\t\t\t\tthe recommendation, the ", "@entity-type": "act", "#text": "clause (i) of\n\t\t\t\tsubsection (h)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4/sp:A/cl:i", "@proposed": "true"}, {"#tail": "\n\t\t\t shall issue a\n\t\t\t\tdetermination affirming or denying the recommendation of the\n\t\t\t advisory\n\t\t\t\tcommittee. If the ", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}, {"#tail": " affirms\n\t\t\t the\n\t\t\t\trecommendation of the advisory committee, or if the ", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}, {"#tail": " takes no action regarding the recommendation within 45\n\t\t\t days of\n\t\t\t\treceiving such recommendation, the nonprescription sunscreen\n\t\t\t condition shall be\n\t\t\t\tgenerally recognized as safe and effective, not misbranded, and\n\t\t\t permitted to be\n\t\t\t\tmarketed and sold in accordance with all applicable rules and\n\t\t\t regulations for\n\t\t\t\tover-the-counter drugs.", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug\n\t\t\t Evaluation\n\t\t\t\tand Research", "@value": "Center for Drug Evaluation and Research"}], "#text": "In the case of a\n\t\t\t\trecommendation by the advisory committee described in "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "iddc61ea94ccd64b5e9867ec3152b3bf2c", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of such subsection, the\n\t\t\t ", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4/sp:A/cl:ii", "@proposed": "true"}, {"#tail": " shall issue a determination affirming or\n\t\t\t denying the recommendation of the advisory committee, to be made publicly\n\t\t\t available,\n\t\t\t\twithin 45 days of receiving the recommendation, and inform the\n\t\t\t sponsor that the sponsor must submit additional\n\t\t\t information to the advisory committee in order to continue the\n\t\t\t\treview by the advisory committee.", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug\n\t\t\t\tEvaluation and Research", "@value": "Center for Drug Evaluation and Research"}], "#text": "In the case of a\n\t\t\t\trecommendation described in "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "id7f42b8df85554204bec490178e3ea21f", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of such subsection, the\n\t\t\t ", "@entity-type": "act", "#text": "clause (iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4/sp:A/cl:iii", "@proposed": "true"}, {"#tail": " shall issue a determination affirming\n\t\t\t or denying the recommendation of the advisory committee, to be made\n\t\t\t publicly\n\t\t\t\tavailable, within 45 days of receiving such recommendation,\n\t\t\t and indicate whether\n\t\t\t\tsuch sunscreen condition determined to be not generally recognized\n\t\t\t as safe and\n\t\t\t effective to\n\t\t\t\tbe marketed and sold, unless an application with respect to such\n\t\t\t\tcondition is approved under ", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for\n\t\t\t\tDrug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}, {"#tail": ", or whether additional\n\t\t\t data must be submitted to the advisory committee.", "@entity-type": "act", "#text": "section 505(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}], "#text": "In the case of a\n\t\t\t\trecommendation described in "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "idae4ce6d59928428992d6685027a210d2", "#text": "\n                "}]}, {"#tail": "\n          ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to not\n\t\t\t accept a recommendation of an advisory committee. Such review may be\n\t\t\t conducted at the next\n\t\t\t supervisory\n\t\t\t\tor higher level above the individual who made the determination.", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}, "#text": "Any person may request a supervisory review of a\n\t\t\t\tdetermination of the "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "idCE29932071AA47C096FBE3B87A225110"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t\tbe made to the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:i/p:2/sp:A", "@proposed": "true"}, {"#tail": " not later than 30 days after such decision\n\t\t\t and shall\n\t\t\t\tindicate in the request whether such person seeks an in-person\n\t\t\t meeting or a\n\t\t\t\tteleconference. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall schedule an in-person or\n\t\t\t teleconference\n\t\t\t\treview, if so requested, not later than 30 days after such request\n\t\t\t is made. The\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall issue a decision to the person requesting a review\n\t\t\t under this\n\t\t\t\tparagraph not later than 45 days after the meeting.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "A request described in "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Request for\n\t\t\t\tsupervisory review"}, "#text": "\n                ", "@id": "id78d8367837644f9db9ead57efe4e62e0"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be authorized to overturn\n\t\t\t\ta determination of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " not\n\t\t\t to accept a\n\t\t\t\trecommendation of the advisory committee if the\n\t\t\t supervisory review\n\t\t\t\tresults in a decision by the reviewer that the individual who made\n\t\t\t the\n\t\t\t\tdetermination did not provide reasonable and sufficient substantive\n\t\t\t support for\n\t\t\t\tthe decision to disregard the advisory committee's\n\t\t\t\trecommendation.", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Standard of\n\t\t\t\tsupervisory review"}, "#text": "\n                ", "@id": "idaf69e62cfb6645c0b9a7e8ec07e5211e"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " overturns a determination by the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " not to accept a favorable\n\t\t\t\trecommendation of an advisory committee, the nonprescription\n\t\t\t sunscreen\n\t\t\t\tcondition shall be generally recognized as safe and effective, not\n\t\t\t misbranded,\n\t\t\t\tand permitted to be marketed and sold in accordance with all\n\t\t\t applicable rules\n\t\t\t\tand regulations for over-the-counter drugs.", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}], "#text": "If the "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "header": {"#tail": "\n                ", "#text": "Supervisory\n\t\t\t\treview decision"}, "#text": "\n                ", "@id": "idfd637d9fc85642f59ba067d16a52d514", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "A decision made through supervisory review shall\n\t\t\t\tconstitute final agency action subject to judicial review."}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "header": {"#tail": "\n                ", "#text": "Final agency\n\t\t\t\taction"}, "#text": "\n                ", "@id": "id9A846FDE48AF41B4B70112B7C176FEAD", "@commented": "no"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Supervisory\n\t\t\t\treview of determination"}, "#text": "\n              ", "@id": "id597C0054D6E04C51A039F6715AC8D812"}], "#text": "\n            ", "@id": "idAF0EF215EF2C4C709C82DE57F4ED852A"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(j)"}, "header": {"#tail": "\n            ", "#text": "Reports"}, "paragraph": [{"#tail": "\n            ", "text": {"short-title": {"#tail": ", on\n\t\t\t\tMarch 1, 2015, and every 2 years thereafter, the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "Sunscreen Innovation Act", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                  "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t issue a report\n\t\t\t\tto ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " describing actions taken under this section.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#tail": "\n            ", "#text": "Not later than 1 year after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n              ", "@id": "id4A5099986A7F4F5E881C93BA5A8D2FB3"}, {"#tail": "\n            ", "@id": "id021FCE2407114618B8178007EA14F315", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Contents"}, "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall include\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:j/p:1", "@proposed": "true"}, "#text": "The\n\t\t\t\treports under "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"short-title": {"#tail": ", including the number of pending applications\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Sunscreen Innovation\n\t\t\t\tAct", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                    "}, "#tail": "\n                ", "#text": "a review of the\n\t\t\t\tprogress made in issuing in a timely manner decisions on the safety\n\t\t\t and\n\t\t\t\teffectiveness for sunscreen conditions for applications pending as\n\t\t\t of the date\n\t\t\t\tof enactment of the "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "reviewed and the\n\t\t\t\tdecision times for each application, measured from the date of\n\t\t\t original\n\t\t\t\teligibility application submission by the sponsor;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id0C47EFF713D84ED29765B07CA5BA395B", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "resulting in a\n\t\t\t\tdetermination of generally recognized as safe and effective and not\n\t\t\t\tmisbranded;"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "id608C7859176C4E129ED073F7E032B16E", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "resulting in a\n\t\t\t\tdetermination of not generally recognized as safe and effective and\n\t\t\t not\n\t\t\t\tmisbranded and the reasons for such determinations; and"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "idE11AF46967FC40A4A76E8F26D9DA6490", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "for which a\n\t\t\t\tdetermination has not been made, an explanation for the delay, a\n\t\t\t description of\n\t\t\t\tthe current status of each such application, and the length of time\n\t\t\t such\n\t\t\t\tapplications have been pending, measured from the date of original\n\t\t\t eligibility\n\t\t\t\tapplication submission by the sponsor;"}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "id7E61E490F2D64E518CBDF2A8D5EDE1B4", "#text": "\n                  "}], "#text": "\n                ", "@id": "id92A84768472B4088B110296ACA097D95"}, {"#tail": "\n              ", "text": {"short-title": {"#tail": ", including the number of such applications\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Sunscreen Innovation\n\t\t\t\tAct", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                    "}, "#tail": "\n                ", "#text": "a review of the\n\t\t\t\tprogress made in issuing in a timely manner a decision on safety\n\t\t\t and\n\t\t\t\teffectiveness for sunscreen condition applications submitted after\n\t\t\t the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "reviewed and the\n\t\t\t\tdecision times for each application;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "idC3A9A27BC19E4FE28316D081447EE68E", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "resulting in a\n\t\t\t\tdetermination of generally recognized as safe and effective and not\n\t\t\t misbranded;\n\t\t\t\tand"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "idAC747645164848B9A09BAEC779C183A9", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "resulting in a\n\t\t\t\tdetermination of not generally recognized as safe and effective and\n\t\t\t not\n\t\t\t\tmisbranded and the reasons for such determinations;"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "idE4B16F304D18405D923AB993AC5F6CF8", "#text": "\n                  "}], "#text": "\n                ", "@id": "idFA27F71040FF44FB8576886B862A6D47"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "a description of\n\t\t\t\tthe staffing and resources relating to the costs associated with\n\t\t\t the review and\n\t\t\t\tdecisionmaking pertaining to applications;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "idCC91246580CF441389C09C0FE65DAAC3", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "a review of the\n\t\t\t\tprogress in meeting the deadlines with respect to processing\n\t\t\t applications under\n\t\t\t\tthis section;"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "id4c31d2d3eb964d59b3c02b28c35baeb0", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines appropriate, recommendations for process\n\t\t\t improvements in\n\t\t\t\tthe handling of pending and new applications; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "to the extent the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "id4c0754c503a246e381709ed87ef6555b", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "recommendations\n\t\t\t\tfor expanding the applicability of this section to nonprescription\n\t\t\t active\n\t\t\t\tingredients or conditions that are not related to the sunscreen\n\t\t\t category of\n\t\t\t\tover-the-counter drugs."}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "idDB4EDC065DDC49F7B0EEDCB527861522", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall publish the reports required under this subsection\n\t\t\t in the\n\t\t\t\tmanner the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " determines to be the most effective for\n\t\t\t efficiently\n\t\t\t\tdisseminating the report, including publication of the report on\n\t\t\t the Internet\n\t\t\t\twebsite of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Method"}, "#text": "\n              ", "@id": "id44340A0E006A4C63936298CB9C55AE51"}], "#text": "\n            ", "@id": "id58CA10D2CB3B416F974CAFA3195761C2"}, {"#tail": "\n        ", "enum": {"#tail": "\n            ", "#text": "(k)"}, "header": {"#tail": "\n            ", "#text": "Rules of\n\t\t\t\tconstruction"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " authority to withdraw or suspend from the\n\t\t\t market\n\t\t\t a drug that\n\t\t\t\tthe ", "@entity-type": "federal-body", "#text": "Secretary's", "@entity-id": "7500"}, {"#tail": " determines to be unsafe or ineffective.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Nothing in this section shall be construed to\n\t\t\t\talter the "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Authority to\n\t\t\t\twithdraw or suspend"}, "#text": "\n              ", "@id": "id93375E09D5CC42B6B0C661AAC4F26B07"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tauthority to review nonprescription conditions other than sunscreen\n\t\t\t\tconditions.", "@entity-type": "federal-body", "#text": "Secretary's", "@entity-id": "7500"}, "#text": "Nothing in the section shall affect the "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Other\n\t\t\t\tconditions"}, "#text": "\n              ", "@id": "idCAF8FD8BD7CB49C69C69735F478D4C56"}], "#text": "\n            ", "@id": "idD9FB621EE1AA417599CC41A5CB5E0927"}], "#text": "\n          ", "@id": "id09E5D37489EC4D84A278A032DBA7F932"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id5F583987F3AF41AFA88E640167C2B510"}, "#text": "\n      ", "@id": "id2657d9a11c6d44dcafa545cc09b3192e"}, {"#tail": "\n  ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t issue determinations with respect to\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Not later\n\t\t\t than 180 days after the date of enactment of this Act, the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Sunscreen\n\t\t\t testing and labeling"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "the appropriate testing and labeling\n\t\t\t requirements for sunscreens sold as an aerosol; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "idCF236921E93F418481C0E0ED8BDCCF9A", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "whether sunscreen may contain a label\n\t\t\t indicating a sun protection factor greater than 50.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "id914B7DEC59664ADB9EB94BCC5DAC6C35", "#text": "\n        "}], "#text": "\n      ", "@id": "id9B8BABF0397C43BBBAA5979D7B0E6A04"}], "#text": "\n    "}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-03-13"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S2141 IS: Sunscreen Innovation Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}